New scan may spare prostate cancer patients unnecessary surgery

NCT ID NCT06389786

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a combined PET/MRI scan using a radioactive tracer can accurately detect if prostate cancer has spread to nearby lymph nodes. Fifty men with high-risk localized prostate cancer will receive the scan before their planned prostate removal surgery. The results will be compared to the actual findings from lymph node tissue removed during surgery to see how well the scan predicts spread.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
18F-rhPSMA-7.3 (a radioactive tracer for PET imaging)
What this could lead to
If successful, this imaging method could help doctors decide which patients need lymph node removal during prostate cancer surgery, avoiding unnecessary procedures.
What could go wrong
This is a small, early-stage study (50 participants) focused on accuracy, not treatment. The scan may not be accurate enough to replace standard surgery in all cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALIZED PROSTATE CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Mayo Clinic in Florida

    RECRUITING

    Jacksonville, Florida, 32224-9980, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.